We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Superbright, Fast X-Rays Can Visualize Just One Layer of Proteins

By LabMedica International staff writers
Posted on 23 Feb 2014
Scientists are now using exceptionally bright and fast X-rays that can capture an image of a protein that rivals traditional techniques with a sheet of protein only one protein-molecule-thick.

A protein’s shape is crucial for understanding how it causes disease or toxicity. More...
Researchers who use X-rays to take images of proteins need a billion copies of the same protein stacked and packed into a well-ordered crystal.

Using a type of laser known as the X-ray free electron laser (XFEL), the technique creates ways to determine the structural characteristics of nearly 25% of known proteins, many of which have been missed because of their inability to stack effectively. The team of researchers led by the US Department of Energy’s (DOE) Pacific Northwest National Laboratory (PNNL; Richland, WA, USA) and Lawrence Livermore National Laboratory (LLNL; Livermore, CA, USA) reported their findings with this innovative type of X-ray diffraction in the March 2014 issue of the International Union of Crystallography Journal. “In this paper, we’re proving it’s possible to use an XFEL to study individual monolayers of protein,” said PNNL microscopist Dr. James Evans. “Just being able to see any diffraction is brand new.”

Dr. Evans is co-leader of the team of two dozen scientists with LLNL physicist Dr. Matthias Frank. The bright, fast X-rays were produced at the Linac Coherent Light Source (LCLS) at the SLAC US National Accelerator Laboratory (Menlo Park, CA, USA), the newest of DOE’s major X-ray light source facilities at the national laboratories. LCLS, currently the world’s most powerful X-ray laser, is an X-ray free-electron laser. It generates beams millions of times brighter than earlier X-ray light sources.

At approximately 0.8 nanometer resolution, the proteins appear somewhat fuzzy but match the predicted view based on earlier studies. Dr. Evans reported that this degree of clarity would allow researchers, in some instances, to visualize how proteins alter their shape as they interact with other proteins or molecules in their environment.

To obtain a better view of protein monolayers using XFEL, the scientists will need to enhance the resolution to 0.1 to 0.3 nanometers, as well as capture images of the proteins at different angles, efforts for which are currently ongoing. Researchers have been using X-ray crystallography for over 60 years to determine the shape and form of proteins that form the inner workings of a living organism’s cells. The conventional technology requires, however, that proteins stack into a large crystal, similar to how oranges stack in a crate. The structure of more than 80,000 proteins have been determined this way, leading to a better understanding of diseases, pathogens, and how organisms grow and develop.

However, many proteins found in natural surroundings do not stack easily. Some protrude from the fatty membranes that cover cells, identifying and interacting with other cells and objects, such as bacteria or viruses, in the surrounding area. These proteins are not used to having others of their kind stack on top. These membrane proteins comprise approximately 25% of all proteins but only 2% of proteins for which researchers have determined structures.

Researchers in the last 10 years have been pursuing the theory that one sheet of proteins could be visualized if the X-rays were bright enough but flashed on and off swiftly enough to limit the damage brought about by the powerful X-rays. Researchers, two years ago, demonstrated they could use XFEL technology on crystals of proteins approximately 15 to 20 sheets thick.

The scientists needed to push this further and worked on a way to create one-sheet-thick crystals of two different proteins: a protein called streptavidin and the membrane protein bacteriorhodopsin. The structures of both proteins are well known to scientists, which gave them something with which to compare their findings. The scientists shined the super-bright X-rays for about 30 femtoseconds on the protein crystals. They created so much data in the process that it took them more than one year to study all of it.

The resulting images look like the known structures, confirming that this technology works. Next, the researchers will try to capture proteins changing shape as they engage in a chemical reaction. For this, even shorter flashes of X-rays might be needed to see the action clearly. If effective, shorter flashes of XFEL might mean longer lines at SLAC.

Related Links:

Pacific Northwest National Laboratory
Lawrence Livermore National Laboratory



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.